Bears Kneecapped After Private Payroll Data Dump, Trump Hits Tariff Button
Marked safe from being a “bear” today…
Well after yesterday's hell hole, we saw a different light today. A light, I might add, that had every stonk and their mom jacked to the t*ts regardless of Iran-related headlines and TACO threats. Case in point: The Dow ripped 238 points higher Wednesday, the S&P 500 clawed back into the green for the week (+.78%), and the Nasdaq said "hold my beer” with a 1.29% face-melter. Translation: The market's ability to shrug off geopolitical chaos and rally on a decent jobs print is genuinely elite-level.
In short, two economic data drops did all the heavy lifting. ADP's private payrolls came in hotter than expected, and the ISM services number showed better-than-expected growth with… and this is the part that got traders horned up… easing inflation pressures. So you’re telling me there’s a chance… for a rate cut?
Ameriprise's Anthony Saglimbene put it plainly: the "deteriorating labor market" narrative is getting "challenged right now." And all God's people said Amen. Additionally, chips gave AI bubble mouth breathers the business as Micron and AMD both ripped +5%, while Broadcom and Nvidia each added around 2%. Broadcom's move came ahead of its fiscal Q1 earnings after the bell as the bean counters on Wall Street are looking for $2.03 EPS on $19.18 billion in revenue. We shall see about that, about that we shall see.
Over in “helth” land, Moderna had its best day since January… shares up 16%... after settling its patent beef with Arbutus Biopharma (+1.28%) and Genevant Sciences. Side note: Is it just me or does the mRNA crew finally catching a bid feel almost nostalgic? Elsewhere, CoreWeave popped 8% on a multiyear deal with Perplexity, who just so happened to completely nuke the need of a Bloomberg Terminal with their new Perplexity Computer. I’m not saying Michael B has been punching air ever since the announcement earlier this week… but I’m definitely not saying he hasn’t.
Meanwhile, Dow Inc., the actual chemical company, not the index (yes, this still confuses people… and by people, I mean me.), caught a 5% bump after KeyBanc upgraded to overweight. The thesis: higher oil prices from the Iran situation benefit U.S. ethylene producers. FactSet flagged that 11-15% of global ethylene capacity is directly tied to the conflict. Low inventories in the U.S. and Europe make that math pretty straightforward.
Oh, and Palantir is still choosing violence. Up 4% Wednesday after already surging 7%+ over the first two sessions this week. Peter Thiel's favorite government contractor remains the cockroach of this market… and I mean that with the highest possible respect. Unkillable. As for the tariffs that bring back the glory of the early 2025 aughts… Trump's 15% global tariff goes live this week. Treasury Secretary Bessent casually mentioned rates would return to pre-Supreme Court levels "within five months," which is either #1. Reaussuring or #2. the kind of timeline that means absolutely nothing. Regardless, markets didn’t either way. They had chips to buy.
Meaning, if there’s anything to take away from today's madness it’s this: good data still beats bad vibes. Every single time. Bears got the geopolitical catalyst they wanted, and the market just... bought the dip anyway. YOLO. Until next time, friends…
If you read all of this, congrats for having a 10 second attention span (better than me). As always, here’s our heatmap for today.

☕ Market Gossip
> Trump sides with crypto firms in trillion-dollar battle with banks over stablecoin yield (CNBC): Jamie Dimon just went from six to midnight…
> US to Pay Interest If Ordered to Refund Importers Over Tariffs (Bloomberg): Bean counters at the IRS just threw up in their mouth a little bit…
> The US military is still using Claude — but defense-tech clients are fleeing (TechCrunch): I’ll take “Do as I say, not as I do” for $500, please…
> Rep. Tony Gonzales will face House ethics panel probe over ‘sexual misconduct’ claim (CNBC): BONK. Go directly to horny jail.
“WTF” Meme of the Day

At the time of publishing, Stocks.News holds positions in Moderna as mentioned in the article.